JANSSEN WILL TELECONFERENCE AHCPR CANCER PAIN GUIDELINES
JANSSEN WILL TELECONFERENCE AHCPR CANCER PAIN GUIDELINES to 10 cities on April 21. Organized by Janssen and the American Pain Society, the teleconference will precede the annual meeting of the State Cancer Pain Initiatives on April 22-25. The program is part of an ongoing educational campaign by Janssen to educate both physicians and patients about treating chronic cancer pain. Janssen markets Duragesic, a transdermal fentanyl patch for chronic cancer pain.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth